Charles River Laboratories International, Inc. (CRL) is likely to grow in the coming quarters, backed by the strong prospects of the RMS (Research Models and Services) segment. Presently, the company is the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide. Stable solvency is an added upside.However, headwinds related to foreign exchange fluctuations and competitive pressure remain concerning for CRL’s operations.In the past year, this Za ...